Albumin (human)

Preview FDA label, BPL, intravenous, effective 2024-12-31. Full label on DailyMed

Quoted from the FDA label. Product labels differ by manufacturer and change over time; confirm against the label for the product you are using. Not yet reviewed by a ClinDose pharmacist.

Dosing in kidney impairment

Examples of such conditions are: Decompensated heart failure Hypertension Esophageal varices Pulmonary edema Hemorrhagic diathesis Severe anemia Renal and post-renal anuria 5.3 Laboratory Parameters 20% - 25% human albumin solutions are relatively low in electrolytes compared to 4% - 5% human albumin solutions so if comparatively large volumes are to be replaced, care must be taken to ensure adequate substitution of other blood constituents (coagulation factors, electrolytes, platelets and erythrocytes). 5.4 Clinical Hemodynamics Parameters Colloid-osmotic effect of human albumin 25% is approximately five times that of blood plasma.

IndicationDose
HypovolemiaAdults: Initial dose of 25 g (including renal dialysis). For acute liver failure: initial dose of 12 to 25 g. (2.1)
Prevention of central volume depletion after paracentesis due to cirrhotic ascitesAdults: 8 g for every 1000 mL of ascitic fluid removed. (2.1)
Hypoalbuminemia including from burnsAdults: 50 to 75 g For pre- and post-operative hypoproteinemia: 50 to 75 g. For burn therapy after the first 24 h: initial dose of 25 g and dose adjustment to maintain plasma protein concentration of 2.5 g per 100 mL. Third space protein loss due to infection: initial dose of 50 to 100 g. (2.1)
Acute nephrosisAdults: 25 g together with diuretic once a day for 7-10 days. (2.1)
Adult respiratory distress syndrome (ARDS)Adults: 25 g over 30 minutes and repeated at 8 hours for 3 days, if necessary. (2.1)
Cardiopulmonary bypass proceduresAdults: Initial dose of 25 g. (2.1)
IndicationDose
HypovolemiaHypovolemia Adults: Initial dose of 25 g. If hemodynamic stability is not achieved within 15 to 30 minutes, an additional dose may be given. For acute liver failure: initial dose of 12 to 25 g. An infusion rate of 1-2 mL per minute is usually indicated. For renal dialysis; the initial dose should not exceed 25 g and patients should be carefully observed for signs of fluid overload.
Prevention of central volume depletion after paracentesis due to cirrhotic ascitesAdults: 8 g for every 1000 mL of ascitic fluid removed.
Hypoalbuminemia including from burnsAdults: 50 to 75 g For pre- and post-operative hypoproteinemia: 50 to 75 g. In burns, therapy usually starts with administration of large volumes of crystalloid solution to maintain plasma volume. After 24 hours: initial dose of 25 g and dose adjustment to maintain plasma protein concentration of 2.5 g per 100 mL or a serum protein concentration of 5.2 g per 100 mL. Third space protein loss due to infection or burns: initial dose of 50 to 100 g. An infusion rate of 1-2 mL per minute is usually indicated in the absence of shock. Treatment should always be guided by hemodynamic response.
Acute nephrosisAdults: 25 g together with diuretic once a day for 7-10 days
Adult respiratory distress syndrome (ARDS)Adults: 25 g over 30 minutes and repeated at 8 hours for 3 days, if necessary.
Cardiopulmonary bypass proceduresAdults: Initial dose of 25 g. Additional amounts may be administered as clinically indicated.

Preparation and administration

Dose The concentration of ALBUMINEX 25% used, its dosage, and infusion rate should be adjusted to the patient's individual requirements and clinical indication. [See table below.]

Administration Visually inspect the solution for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if there are any particulates seen or if the solution is discolored. If a large volume is infused, ensure that the vial is at room temperature before infusion.

Do not dilute with Sterile Water for Injection as hemolysis may occur. ALBUMINEX 25% may be diluted with 0.9% saline or 5% dextrose. Begin the infusion within 4 hours of piercing the vial stopper (the product does not contain any preservative). Adjust the rate of infusion according to the individual patient's hemodynamic and other physiological responses, using appropriate clinical monitoring.

IndicationDose
HypovolemiaAdults: Initial dose of 25 g (including renal dialysis). For acute liver failure: initial dose of 12 to 25 g. (2.1)
Prevention of central volume depletion after paracentesis due to cirrhotic ascitesAdults: 8 g for every 1000 mL of ascitic fluid removed. (2.1)
Hypoalbuminemia including from burnsAdults: 50 to 75 g For pre- and post-operative hypoproteinemia: 50 to 75 g. For burn therapy after the first 24 h: initial dose of 25 g and dose adjustment to maintain plasma protein concentration of 2.5 g per 100 mL. Third space protein loss due to infection: initial dose of 50 to 100 g. (2.1)
Acute nephrosisAdults: 25 g together with diuretic once a day for 7-10 days. (2.1)
Adult respiratory distress syndrome (ARDS)Adults: 25 g over 30 minutes and repeated at 8 hours for 3 days, if necessary. (2.1)
Cardiopulmonary bypass proceduresAdults: Initial dose of 25 g. (2.1)
IndicationDose
HypovolemiaHypovolemia Adults: Initial dose of 25 g. If hemodynamic stability is not achieved within 15 to 30 minutes, an additional dose may be given. For acute liver failure: initial dose of 12 to 25 g. An infusion rate of 1-2 mL per minute is usually indicated. For renal dialysis; the initial dose should not exceed 25 g and patients should be carefully observed for signs of fluid overload.
Prevention of central volume depletion after paracentesis due to cirrhotic ascitesAdults: 8 g for every 1000 mL of ascitic fluid removed.
Hypoalbuminemia including from burnsAdults: 50 to 75 g For pre- and post-operative hypoproteinemia: 50 to 75 g. In burns, therapy usually starts with administration of large volumes of crystalloid solution to maintain plasma volume. After 24 hours: initial dose of 25 g and dose adjustment to maintain plasma protein concentration of 2.5 g per 100 mL or a serum protein concentration of 5.2 g per 100 mL. Third space protein loss due to infection or burns: initial dose of 50 to 100 g. An infusion rate of 1-2 mL per minute is usually indicated in the absence of shock. Treatment should always be guided by hemodynamic response.
Acute nephrosisAdults: 25 g together with diuretic once a day for 7-10 days
Adult respiratory distress syndrome (ARDS)Adults: 25 g over 30 minutes and repeated at 8 hours for 3 days, if necessary.
Cardiopulmonary bypass proceduresAdults: Initial dose of 25 g. Additional amounts may be administered as clinically indicated.